ABSTRACT This cross-sectional study involves 100 multiple sclerosis (MS) and 100 non-MS patients, under the age of 60 years old, with nasal obstruction, traumatic brain injury, previous rhinoplasty or neurosurgery, and so forth. Objective To assess olfactory function using the Connecticut test and verify correlations between olfactory alteration, disease duration and the Expanded Disability Status Scale (EDSS). Methods One hundred MS patients and 100 healthy control patients responded to a questionnaire. Those with olfactory alteration underwent a facial CT to exclude other causes. Results Thirty-two percent of patients showed alterations, compared with 3% in the healthy control group. Patients having EDSS above 4, showed a 5.2-times ...
The present study assessed odour threshold, discrimination and identification in relapsing-remitting...
Background The aim of the study was to investigate changes of the olfactory and gustatory capacity ...
BACKGROUND: Multiple Sclerosis (MS) is a neuroinflammatory, neurodegenerative, demyelinating disease...
Multiple sclerosis (MS) is a chronic inflammatory disease and one of the leading causes of disabilit...
Several studies reported olfactory dysfunction in patients with multiple sclerosis. The estimate of ...
Background: Several studies reported olfactory dysfunction in patients with multiple sclerosis. The ...
Background: Olfactory function in multiple sclerosis (MS) has not been extensively studied. Anecdota...
Background: Olfactory dysfunction has been reported in multiple sclerosis (MS). However, to date no ...
Introduction: Previous studies have shown that olfactory functioning is affected by multiple scleros...
Existing data suggest that people with multiple sclerosis (pwMS) are at an elevated risk for experie...
Background: The relative contribution to the olfactory dysfunction of the lesions in the specific br...
Previous studies have shown that olfactory functioning is affected by multiple sclerosis (MS). This ...
Background: Both cognition and olfaction are impaired in multiple sclerosis (MS). However, little is...
Background: Both cognition and olfaction are impaired in multiple sclerosis (MS). However, little is...
BACKGROUND Impaired olfactory threshold has been reported in early inflammatory phases of MS, whi...
The present study assessed odour threshold, discrimination and identification in relapsing-remitting...
Background The aim of the study was to investigate changes of the olfactory and gustatory capacity ...
BACKGROUND: Multiple Sclerosis (MS) is a neuroinflammatory, neurodegenerative, demyelinating disease...
Multiple sclerosis (MS) is a chronic inflammatory disease and one of the leading causes of disabilit...
Several studies reported olfactory dysfunction in patients with multiple sclerosis. The estimate of ...
Background: Several studies reported olfactory dysfunction in patients with multiple sclerosis. The ...
Background: Olfactory function in multiple sclerosis (MS) has not been extensively studied. Anecdota...
Background: Olfactory dysfunction has been reported in multiple sclerosis (MS). However, to date no ...
Introduction: Previous studies have shown that olfactory functioning is affected by multiple scleros...
Existing data suggest that people with multiple sclerosis (pwMS) are at an elevated risk for experie...
Background: The relative contribution to the olfactory dysfunction of the lesions in the specific br...
Previous studies have shown that olfactory functioning is affected by multiple sclerosis (MS). This ...
Background: Both cognition and olfaction are impaired in multiple sclerosis (MS). However, little is...
Background: Both cognition and olfaction are impaired in multiple sclerosis (MS). However, little is...
BACKGROUND Impaired olfactory threshold has been reported in early inflammatory phases of MS, whi...
The present study assessed odour threshold, discrimination and identification in relapsing-remitting...
Background The aim of the study was to investigate changes of the olfactory and gustatory capacity ...
BACKGROUND: Multiple Sclerosis (MS) is a neuroinflammatory, neurodegenerative, demyelinating disease...